The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer
Coronavirus-19 (COVID-19)-induced effects on deferred diagnosis and treatment of bladder cancer (BC) patients are currently not clarified. The aim of this study was to evaluate outcomes of the COVID-19 pandemic by considering its effects on tumor stage and grade, and to create feasible clinical tria...
Main Authors: | Gennadi Tulchiner, Nina Staudacher, Josef Fritz, Christian Radmayr, Zoran Culig, Wolfgang Horninger, Renate Pichler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1754 |
Similar Items
-
Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature
by: G. A. Taarnhøj, et al.
Published: (2019-01-01) -
The papilla as a biomarker in the molecular era of bladder oncology
by: Luciana Schultz
Published: (2018-12-01) -
En Bloc Resection of Bladder Tumor—Is It the Way Forward?
by: Christian Daniel Fankhauser, et al.
Published: (2021-05-01) -
Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer
by: Mubarak Al-mansour, et al.
Published: (2014-01-01) -
BCG Induced Necrosis of the Entire Bladder Urothelium
by: Malte Krönig, et al.
Published: (2015-09-01)